Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Luger, A., Broersen, L. H. A., Biermasz, N. R., Biller, B. M. K., Buchfelder, M., Chanson, P., Jorgensen, J. O. L., Kelestimur, F., Llahana, S., Maiter, D., Mintziori, G., Petraglia, F., Verkauskiene, R., Webb, S. M. & Dekkers, O. M. (2021). Ese clinical practice guideline on functioning and nonfunctioning pituitary adenomas in pregnancy. European Journal of Endocrinology, 185(3), G1-G33. https://doi.org/10.1530/EJE-21-0462
Madsen, L. R., Gibbons, K. S., Ma, R. C. W., Tam, W. H., Catalano, P. M., Sacks, D. A., Lowe, J. & McIntyre, H. D. (2021). Do variations in insulin sensitivity and insulin secretion in pregnancy predict differences in obstetric and neonatal outcomes? Diabetologia, 64(2), 304-312. https://doi.org/10.1007/s00125-020-05323-0
Marouli, E., Yusuf, L., Kjaergaard, A. D., Omar, R., Kuś, A., Babajide, O., Sterenborg, R., Åsvold, B. O., Burgess, S., Ellervik, C., Teumer, A., Medici, M. & Deloukas, P. (2021). Thyroid Function and the Risk of Alzheimer's Disease: A Mendelian Randomization Study. Thyroid, 31(12), 1794-1799. https://doi.org/10.1089/thy.2021.0321
Martel-Duguech, L. M., Jorgensen, J. O. L., Korbonits, M., Johannsson, G., Webb, S. M. & European Society of Endocrinology (2021). ESE audit on management of Adult Growth Hormone Deficiency in clinical practice. European Journal of Endocrinology, 184(2), 323-334. https://doi.org/10.1530/EJE-20-1180
Martos-Rodríguez, C. J., Albarrán-Juárez, J., Morales-Cano, D., Caballero, A., MacGrogan, D., de la Pompa, J. L., Carramolino, L. & Bentzon, J. F. (2021). Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(9), E427-E439. https://doi.org/10.1161/ATVBAHA.120.315627
McClung, M. R., Bolognese, M. A., Brown, J. P., Reginster, J. Y., Langdahl, B. L., Shi, Y., Timoshanko, J., Libanati, C., Chines, A. & Oates, M. K. (2021). Skeletal responses to romosozumab after 12 months of denosumab. JBMR Plus, 5(7), Article e10512. https://doi.org/10.1002/jbm4.10512